Clinical trial
Rosiglitazone Effects on Cognition for Adults in Later Life
NCT00242593 · University of Washington, Other · Unknown status
Key facts
| NCT number | NCT00242593 |
|---|---|
| Title | Rosiglitazone Effects on Cognition for Adults in Later Life |
| Official title | The Effects of Rosiglitazone on Cognition in Patients With MCI |
| Acronym | RECALL |
| Lead sponsor | University of Washington, Other |
| Collaborators | National Institute on Aging (NIA) NIH GlaxoSmithKline Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Mild Cognitive Impairment |
| Intervention type | Drug |
| Interventions | Rosiglitazone |
| Enrollment | 120 |
| Start date | Jun 1, 2006 |
| Primary completion | Dec 1, 2011 |
| Completion | Dec 1, 2011 |
| First posted | Oct 20, 2005 |
| Last update posted | Aug 5, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: